Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (111-120 of 321) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Exacerbation of cerebral radiation necrosis by bevacizumabDeva Sanjeeva Jeyaretna, William T Curry, Tracy T Batchelor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastomaManish Aghi, Paola Gaviani, John W Henson, et al.
Neuro-Oncology|April 22, 2010
Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranibElizabeth R Gerstner, Poe-Jou Chen, Patrick Y Wen, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 26, 2010
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patientsScott R Plotkin, Chris Halpin, Michael J McKenna, et al.
Neuro-Oncology|March 5, 2019
Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncologySebastian F Winter, Franziska Loebel, Jay Loeffler, et al.
Physical Review Letters|October 15, 2013
Wilson ratio of fermi gases in one dimensionX-W Guan, X-G Yin, A Foerster, et al.
Expert Opinion on Investigational Drugs|November 29, 2007
Antiangiogenic agents for the treatment of glioblastomaElizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Oncotarget|November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastomaIsabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.
Journal of Neuropathology and Experimental Neurology|December 6, 2006
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survivalMasahiro Mizoguchi, Rebecca A Betensky, Tracy T Batchelor, et al.
Neuro-Oncology|October 11, 2017
Glioblastoma in elderly patients: solid conclusions built on shifting sand?Antje Wick, Tobias Kessler, Andrew E H Elia, et al.
Pageof 33

Showing results (111-120 of 321) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Exacerbation of cerebral radiation necrosis by bevacizumabDeva Sanjeeva Jeyaretna, William T Curry, Tracy T Batchelor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastomaManish Aghi, Paola Gaviani, John W Henson, et al.
Neuro-Oncology|April 22, 2010
Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranibElizabeth R Gerstner, Poe-Jou Chen, Patrick Y Wen, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 26, 2010
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patientsScott R Plotkin, Chris Halpin, Michael J McKenna, et al.
Neuro-Oncology|March 5, 2019
Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncologySebastian F Winter, Franziska Loebel, Jay Loeffler, et al.
Physical Review Letters|October 15, 2013
Wilson ratio of fermi gases in one dimensionX-W Guan, X-G Yin, A Foerster, et al.
Expert Opinion on Investigational Drugs|November 29, 2007
Antiangiogenic agents for the treatment of glioblastomaElizabeth R Gerstner, Dan G Duda, Emmanuelle di Tomaso, et al.
Oncotarget|November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastomaIsabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.
Journal of Neuropathology and Experimental Neurology|December 6, 2006
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survivalMasahiro Mizoguchi, Rebecca A Betensky, Tracy T Batchelor, et al.
Neuro-Oncology|October 11, 2017
Glioblastoma in elderly patients: solid conclusions built on shifting sand?Antje Wick, Tobias Kessler, Andrew E H Elia, et al.
Pageof 33